Czechia· CZ-0269115

GRANDAXIN

A tofisopam product containing tofisopam, registered in Czechia by Egis Pharmaceuticals PLC, Budapešť. The same ATC class is registered in 2 of our 19 countries.

ATC N05BA23

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedGRANDAXINATCN05BA23REGISTER NO.CZ-0269115PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Tofisopam is registered in 2 of 19 countries.

Countries holding a registration under ATC N05BA23 (tofisopam), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 1 of them publish a price we can compare per daily dose

Tofisopam · ATC N05BA23

2 / 19 countries

  • Czechiaprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
TOFISOPAM
Manufacturer
Egis Pharmaceuticals PLC, Budapešť
Country
Czechia (CZ)
ATC code
N05BA23
ATC class
Tofisopam
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N05BA23

Tofisopam, as other registers publish it.

All tofisopam products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Bulgaria · Грандаксин
  • Hungary · Grandaxin
  • Lithuania · Grandaxin
  • Latvia · Grandaxin
  • Slovakia · Grandaxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f99b0faa-d03e-4fe6-afb7-70fca009eb06
GET /v1/drugs/f99b0faa-d03e-4fe6-afb7-70fca009eb06?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "50MG",
  "pack_size": "60",
  "substance": "TOFISOPAM",
  "cz_kod_sukl": "0269115",
  "product_type": "CH",
  "substance_codes": "2715",
  "registration_state": "R",
  "registration_number": "68/009/77-S/C"
}

See everything about tofisopam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.